Atlas Trials

NeoTRACK - Dissection of IO Efficacy in NSCLC by Longitudinal tracKing

Clinical trial NCT05825625 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05825625
Sponsor
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Non-small Cell Lung Cancer
Start date
2023-05-26
Primary completion
2026-12-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.